Clinical Trial Update: State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial funded by the state is evaluating guided psilocybin for recovery from trauma in people with PTSD and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Baylor College of Medicine | Conditions: PTSD | Phase 2 | Status: RECRUITING